Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass

Simple item page
dc.contributor.authorPerez, Gustavo
dc.contributor.authorDevaud, Nicolas
dc.contributor.authorEscalona, Alex
dc.contributor.authorDowney, Patricio
dc.date.accessioned2025-01-21T01:05:53Z
dc.date.available2025-01-21T01:05:53Z
dc.date.issued2006
dc.description.abstractEpidemiological studies have proven that obesity is a significant risk factor for type 2 diabetes. Long-term progression of diabetes leads to various microvascular complications, of which diabetic nephropathy has become of increasing importance, and is the main cause of end-stage renal failure in occidental countries, Microalbuminuria is the first marker of incipient diabetic nephropathy, an early stage glomerulopathy which can progress to renal failure and which historically has been treated with angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor antagonists. We report a severely obese diabetic patient on treatment for diabetic nephropathy with ACE-inhibitors and poor results, which resolved after Roux-en-Y gastric bypass.
dc.fuente.origenWOS
dc.identifier.eissn1708-0428
dc.identifier.issn0960-8923
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/96040
dc.identifier.wosidWOS:000241209200022
dc.issue.numero10
dc.language.isoen
dc.pagina.final1391
dc.pagina.inicio1388
dc.revistaObesity surgery
dc.rightsacceso restringido
dc.subjectdiabetes
dc.subjectmorbid obesity
dc.subjectnephropathy
dc.subjectmicroalbuminuria
dc.subjectgastric bypass
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleResolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass
dc.typeartículo
dc.volumen16
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas